Host: Jonathan Barratt, PhD 



  
    A new class of drugs are looking at the ability to reduce proteinuria and protect the loss of kidney function. So what do clinicians need to know about the treatment landscape for IgA nephropathy? Tune in with Dr. Jonathan Barratt, The Mayer Professor of Renal Medicine at the University of Leicester in the United Kingdom.

Taking a Deep Dive into the Pathophysiology of IgA Nephropathy

Tune in to interviews with the top thought leaders in medicine exploring the clinical and professional issues that are foremost in the minds of the medical community. Join us at the Clinician's Roundtable for discussions on a vast range of topics that every medical professional should know about.

Science & Medicine

Natural Sciences

Social Sciences

Medicine

Health

Alternative Health

Self-Help

Sexuality

Fitness & Nutrition

Host: Charles Turck, PharmD, BCPS, BCCCP 


  Guest: Brian Smith, MD, MPH 



  
    According to the current recommendations, we should be testing all patients with COPD for alpha-1 antitrypsin deficiency (AATD). But unfortunately, there are many barriers that can keep us from following these recommendations. That’s why Dr. Brian Smith joins Dr. Charles Turck to share strategies for addressing those barriers and proactively detecting AATD in patients with COPD. Dr. Smith specializes in Family Medicine and Hospice and Palliative Medicine at Versailles Family Medicine in Kentucky. Click here to order free AlphaID™ screening kits to rule out Alpha-1 deficiency in your patients.  

COPD and Alpha-1: Addressing Testing Barriers in Primary Care

Host: Charles Turck, PharmD, BCPS, BCCCP 


  Guest: David C. Mares, MD 



  
    Several different professional organizations have created guidelines for screening for alpha-1 antitrypsin deficiency (AATD) in COPD that can help us proactively detect and treat patients. Joining Dr. Charles Turck to break down those various guideline recommendations and share best practices for implementing them into clinical practice is Dr. David Mares, who specializes in adult pulmonology and critical care in Anderson, Indiana. Click here to order free AlphaID™ screening kits to rule out Alpha-1 deficiency in your patients.

Alpha-1 Screening in COPD: Translating Guidelines into Clinical Practice

Host: Charles Turck, PharmD, BCPS, BCCCP 


  Guest: David C. Mares, MD 



  
    It’s absolutely critical to proactively detect alpha-1 antitrypsin deficiency (AATD) in our patients with COPD, but it’s just as important to know how to manage patients with this deficiency once we reach a diagnosis. That’s why Dr. David Mares joins Dr. Charles Turck to share his experiences and a patient case in managing AATD-associated COPD. Dr. David Mares is an adult pulmonology and critical care specialist at Ascension St. Vincent Anderson Hospital in Indiana. Click here to order free AlphaID™ screening kits to rule out Alpha-1 deficiency in your patients.

Managing AATD in COPD: Lessons from a Patient Case and Clinical Practice

Host: Jonathan Chung, MD 


  Host: Seth Kligerman, MD 



  
    Learn from experts about differentiating idiopathic pulmonary fibrosis (IPF) from other interstitial lung diseases and the role of radiology in effectively diagnosing IPF with a multidisciplinary team approach. 

Idiopathic Pulmonary Fibrosis: The Role of Radiology in Accurate and Timely Diagnosis

Guest: Ina Park, MD 



  
    The United States has seen its largest increase in syphilis cases in the past five years. And with increases prevalent in every region, along with a shortage of medication, additional surveillance strategies and importation resources are necessary. Dive in for a discussion on the challenges and strategies to combat the spread of syphilis with Dr. Ina Park, Professor of Family Community Medicine at the University of California San Francisco School of Medicine.

Taking a Deep Dive into the Pathophysiology of IgA Nephropathy

Download our free app to listen on your phone